Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
---|
05/03/2001 | WO2000066164A8 Contraceptive compositions containing antiprogestinic and progestinic |
05/03/2001 | CA2389020A1 Sodium-hydrogen exchanger type 1 inhibitor crystals |
04/26/2001 | WO2001029026A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
04/26/2001 | WO2001028992A2 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
04/26/2001 | CA2386910A1 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
04/25/2001 | CN1292279A Medicine for curing emmeniopathy and its preparation method |
04/19/2001 | WO2001027113A2 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES |
04/19/2001 | WO2001027112A1 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors |
04/19/2001 | CA2387353A1 Pharmaceutically active compounds |
04/12/2001 | WO2001025242A1 Novel thiazolo(4,5-d)pyrimidine compounds |
04/12/2001 | WO2001025200A1 Cyclic amine compounds as ccr5 antagonists |
04/12/2001 | WO2000076958A3 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
04/12/2001 | CA2608807A1 Cyclic amine compounds as ccr5 antagonists |
04/05/2001 | WO2001022972A2 Immunostimulatory nucleic acids |
04/05/2001 | CA2388055A1 Immunostimulatory nucleic acids |
04/03/2001 | US6211208 2-aminopyridines containing fused ring substituents |
03/29/2001 | WO2001021596A1 Quinazoline derivatives and their use as pharmaceuticals |
03/29/2001 | WO2001021594A1 Quinazoline compounds and pharmaceutical compositions containing them |
03/29/2001 | WO2000051576A3 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain |
03/29/2001 | CA2384291A1 Quinazoline derivatives and their use as pharmaceuticals |
03/29/2001 | CA2384282A1 Quinazoline compounds and pharmaceutical compositions containing them |
03/22/2001 | WO2001019825A1 Pteridinones as kinase inhibitors |
03/22/2001 | CA2393896A1 Pteridinones as kinase inhibitors |
03/15/2001 | WO2001017976A1 Bis-sulfonamides |
03/15/2001 | WO2001017957A1 Prostaglandin e analogues |
03/15/2001 | WO2001017539A1 Herbal compositions for itchy or infected skin |
03/15/2001 | WO2001017504A1 Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
03/15/2001 | CA2384148A1 Prostaglandin e analogues |
03/08/2001 | WO2001015732A1 Remedies for immunological diseases |
03/08/2001 | WO2001015701A1 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
03/08/2001 | WO2000041546A9 Novel exendin agonist formulations and methods of administration thereof |
03/01/2001 | WO2001014380A1 Isomeric fused pyrrolocarbazoles and isoindolones |
03/01/2001 | WO2001014376A1 Novel spiro compounds |
03/01/2001 | WO2001014353A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
02/27/2001 | US6194408 Parasiticides |
02/22/2001 | WO2001012627A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
02/22/2001 | WO2001012611A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
02/22/2001 | WO2000071538A3 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
02/22/2001 | WO2000023065A8 Storable active substance concentrate with formoterol |
02/22/2001 | CA2381975A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
02/22/2001 | CA2381551A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
02/21/2001 | CN1062151C Medicinal compsn. for treatment of heperosteogeny and its prepn. |
02/20/2001 | US6191140 Potassium channel modulators; muscle relaxants; controlling cell membranes |
02/01/2001 | WO2000056359A3 Vaccine against streptococcus pneumoniae |
01/25/2001 | WO2000056360A3 Vaccine against antigens from bacteriae |
01/18/2001 | WO2001003712A1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement |
01/11/2001 | WO2001002403A1 METHOD FOR PREPARING SUBSTITUTED [1,4]DIAZEPINO[6,7,1-hi]INDOL-4-ONES |
01/11/2001 | WO2000062800A3 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
01/11/2001 | CA2376707A1 Process for the preparation of substituted ¬1,4|diazepino¬6,7,1-hi|indol-4-ones |
01/04/2001 | WO2000056358A3 Vaccine against streptococcus pneumoniae capsular polysaccharides |
12/28/2000 | WO2000078759A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists |
12/28/2000 | CA2375265A1 Polymorphs of crystalline azo-bicyclo 2,2,2,oct-3-yl amine dihydrochloride and their pharmaceutical compositions |
12/21/2000 | WO2000076961A1 Inhibitors of aspartyl protease |
12/21/2000 | WO2000076958A2 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
12/21/2000 | WO2000050047A3 Composition for the treatment of psoriasis |
12/21/2000 | CA2689997A1 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
12/14/2000 | WO2000044763A3 Compositions for treating inflammatory response |
12/07/2000 | WO2000073303A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists |
12/07/2000 | WO2000073298A1 Mutual prodrugs of amlodipine and atorvastatin |
12/07/2000 | WO2000072855A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
12/07/2000 | WO2000037141A9 Combination chemotherapy |
12/07/2000 | CA2372236A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo¬2,2,2|oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists |
11/30/2000 | WO2000071557A1 13-methyl-erythromycin derivatives |
11/30/2000 | WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
11/30/2000 | WO2000041546A3 Novel exendin agonist formulations and methods of administration thereof |
11/29/2000 | CN1274602A Externally applied medicated wine for treating traumatic injury and rheumatism |
11/21/2000 | US6150418 Propellant-free concentrate suitable for storage containing given concentration of formoterol, or salt or addition products thereof as active substance in a solvent or suspension agent; use in inhalation therapy |
11/16/2000 | CA2369605A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
11/09/2000 | WO2000066603A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a |
11/09/2000 | WO2000066602A1 3-deoxy-desmycosin derivatives and process for their preparation |
11/09/2000 | WO2000066556A1 Indoline derivatives as progesterone antagonists |
11/09/2000 | WO2000066164A1 Contraceptive compositions containing antiprogestinic and progestinic |
11/09/2000 | WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
11/09/2000 | CA2372977A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a |
11/09/2000 | CA2372773A1 Contraceptive compositions containing antiprogestinic and progestinic |
11/09/2000 | CA2371638A1 Indoline derivatives as progesterone antagonists |
11/09/2000 | CA2368249A1 3-deoxy-desmycosin derivatives and process for their preparation |
11/02/2000 | WO2000064450A1 Pharmaceutical composition |
10/26/2000 | WO2000062800A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
10/26/2000 | WO2000037064A3 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
10/26/2000 | WO2000025746A3 A process for the preparation of suspensions of drug particles for inhalation delivery |
10/19/2000 | WO2000061590A1 Process for preparing amine platinum complexes |
10/18/2000 | CN1270592A Spiroazabicyclic heterocyclic compounds |
10/12/2000 | CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
10/05/2000 | WO2000058292A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
09/28/2000 | WO2000056360A2 Vaccine against antigens from bacteriae |
09/28/2000 | WO2000056359A2 Vaccine against streptococcus pneumoniae |
09/28/2000 | WO2000056358A2 Vaccine against streptococcus pneumoniae capsular polysaccharides |
09/28/2000 | WO2000056348A1 Inflammatory mediation obtained from atractylodes lancea |
09/28/2000 | CA2367699A1 Inflammatory mediation obtained from atractylodes lancea |
09/28/2000 | CA2366152A1 Streptococcus pneumoniae vaccine |
09/28/2000 | CA2365296A1 Vaccine |
09/20/2000 | CN1267215A Pharmacetical compositions contg. effervescent acid-base couple |
09/12/2000 | CA2212794C Oil in water emulsions containing propofol and edetate |
09/08/2000 | WO2000051602A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
09/08/2000 | WO2000051576A2 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain |
09/08/2000 | CA2366318A1 Novel pharmaceutical, dietary and cosmetic compositions comprising zinger officinale roscoe, eicosapentaenoic acid and/or docosahexaenoic acid |
09/08/2000 | CA2362554A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
09/06/2000 | EP1032408A1 Galenic preparation for prevention and treatment of hepatocarcinoma |
09/06/2000 | CN1265597A Composition comprising propolis and at least an essential oil |